Sharemaestro Newsreel

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …

Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?

Hims & Hers Health, Inc. reported second-quarter 2026 sales of US$753.21 million, up from US$544.83 million a year earlier, but moved from net income of US$42.51 million to a net loss of US$86.29 million, while also raising full-year 2026 revenue guidance to between US$3.10 …

Hims & Hers stock trims losses following quarterly results

What happened: Hims & Hers Health (HIMS) stock declined 3% before trimming losses on Tuesday. What's behind the move: Shares were volatile after the telehealth company swung to a loss of $0.37 per share in the second quarter from a profit of $0.17 a …

Hims & Hers Q2 revenue beat offset by wider-than-expected loss

Hims & Hers Q2 revenue beat offset by wider-than-expected loss Proactive uses images sourced from Shutterstock Hims & Hers Health (NYSE:HIMS) delivered mixed second-quarter results, with revenue beating Wall Street expectations while its quarterly loss came in wider than analysts had forecast as the …

Hims & Hers' Revenue Growth Comes at a Cost

This article first appeared on GuruFocus. Hims & Hers Health, Inc. (NYSE:HIMS) fell 6.11% in premarket after reporting second-quarter revenue of $753.2 million, up 38% year over year and above the $699 million analysts estimate. The company added 452,000 subscribers during the past year, …

Hims & Hers Raises Outlook as Cash Flow Weakens

This article first appeared on GuruFocus. Hims & Hers Health Inc. (HIMS, Financials) the digital health platform, boosted its full-year revenue outlook after another quarter of robust growth, but investors are also getting a better sense of what that expansion will cost. Warning! GuruFocus …

Hims & Hers Health Earnings: What To Look For From HIMS

Hims & Hers Health Earnings: What To Look For From HIMS Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here's what to expect. Hims & Hers Health missed analysts' revenue expectations last quarter, reporting revenues …

Hims & Hers Q2 2026 earnings: loss despite revenue beat

Hims & Hers Health reported a net loss of $86.3 million in the second quarter of 2026, swinging from net income of $42.5 million in the same period a year earlier, even as revenue climbed 38% to $753.2 million. The company raised its full-year …

Hims & Hers anticipates $880M-$900M Q3 revenue while raising 2026 outlook to $3.1B-$3.3B

Earnings Call Insights: Hims & Hers Health (HIMS) Q2 2026 MANAGEMENT VIEW * "In the second quarter, we welcomed more than 300,000 subscribers, bringing our global subscriber base to nearly 3 million people." (Co-Founder, Chairman & CEO Andrew Dudum) * "In June, we became …

Hims & Hers Health Inc (HIMS) (Q2 2026) Earnings Call Highlights: Revenue Surges 40% to ...

This article first appeared on GuruFocus. Revenue: Grew nearly 40% year-over-year to more than $753 million in the second quarter. Subscribers: Added 300,000 net new subscribers, ending the quarter with nearly 3 million. Domestic Revenue: Accelerated to 16% year-over-year growth, generating $622 million. International …

Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates

Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items. …

Hims & Hers Lowers Profit Forecast, Shares Drop

Hims & Hers Health shares are down after the telehealth firm reduced the top end of its adjusted Ebitda forecast for the full year. Madison Muller reports on "Bloomberg The Close." View Comments

Hims Stock Falls on Earnings. Why a Guidance Hike Isn’t Enough.

Hims faces restructuring charges as it shifts its U.S. weight-loss business away from compounded GLP-1 medications. Continue Reading

Hims Topples As Obesity Kingpin Hits A Snag On Weighty Second-Quarter Loss

Hims stock fell late Monday after its second-quarter loss came in bigger than expected, upsetting a sales beat. Continue Reading

Hims & Hers shares fall after second-quarter wider-than-expected loss

Investing.com -- Hims & Hers Health reported a wider-than-expected second-quarter loss on Monday, sending its shares down 1.5%. The company reported a loss of 37 cents per share, compared with analysts' estimate of a loss of 5 cents per share. Revenue rose 38% year …

Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops

Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops Telehealth company Hims & Hers Health (NYSE:HIMS) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 38.2% year on year to $753.2 million. On top of that, next …

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

Revenue of approximately $753 million, up 38% year-over-year in Q2 2026 Subscribers grew to nearly 2.9 million, up 19% year-over-year in Q2 2026 Raises full year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and updates Adjusted EBITDA guidance to …

HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

RADNOR, Pa., Aug. 09, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who …

Zoetis Q2 Earnings Call Highlights

Key Points Interested in Zoetis Inc.? Here are five stocks we like better. Zoetis reported mixed second-quarter results: Revenue was $2.5 billion, flat reported and down 1% organically, while adjusted EPS rose 4% to $1.87 due partly to share repurchases. Weak U.S. companion-animal demand …

Zoetis Cut Its 2026 Guide in Q2 Earnings. The Dermatology Lead Is the Reason.

Hims & Hers Health (HIMS) Responds To FTC Lawsuit Over Patient Data Use

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Hims & Hers Health (NYSE:HIMS) has issued a public response to a Federal Trade Commission lawsuit that challenges aspects of its telehealth practices …

Hims & Hers Health (HIMS) Launches AI Weight Loss Care, Is It Still A Bargain?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Hims & Hers Health (HIMS) just introduced an AI powered care experience for Hers weight loss members, including a connected smart scale and app …

HIMS & HERS HEALTH INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Hims & Hers Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers (HIMS) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Hims & Hers and would like to discuss your legal …

Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?

Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2026 results on Aug. 10, after the closing bell. In the last reported quarter, the company's loss per share of 18 cents lagged the Zacks Consensus Estimate of earnings per share of 4 …

Informe de resultados: Zoetis presenta resultados mixtos en el segundo trimestre de 2026